Equities Research Analysts’ Price Target Changes for August 3rd (AMLX, BWIN, CTVA, DASH, EMN, FSLR, LHX, LIN, MGA, NXT)

Equities Research Analysts’ price target changes for Monday, August 3rd:

Amylyx Pharmaceuticals (NASDAQ:AMLX) had its target price increased by Citigroup Inc. from $20.00 to $26.00. The firm currently has a buy rating on the stock.

Baldwin Insurance Group (NASDAQ:BWIN) had its price target boosted by UBS Group AG from $35.00 to $37.00. UBS Group AG currently has a buy rating on the stock.

Corteva (NYSE:CTVA) had its price target increased by UBS Group AG from $86.00 to $89.00. The firm currently has a neutral rating on the stock.

DoorDash (NASDAQ:DASH) had its target price increased by UBS Group AG from $214.00 to $223.00. UBS Group AG currently has a neutral rating on the stock.

Eastman Chemical (NYSE:EMN) had its target price lowered by Citigroup Inc. from $85.00 to $81.00. They currently have a buy rating on the stock.

First Solar (NASDAQ:FSLR) had its target price raised by Citigroup Inc. from $294.00 to $297.00. They currently have a buy rating on the stock.

L3Harris Technologies (NYSE:LHX) had its price target reduced by UBS Group AG from $312.00 to $298.00. They currently have a neutral rating on the stock.

Linde (NASDAQ:LIN) had its price target reduced by Citigroup Inc. from $600.00 to $580.00. The firm currently has a buy rating on the stock.

Magna International (NYSE:MGA) (TSE:MG) had its target price boosted by Scotiabank from $74.00 to $78.00. Scotiabank currently has a sector outperform rating on the stock.

Nextpower (NASDAQ:NXT) had its target price reduced by Citigroup Inc. from $145.00 to $132.00. They currently have a buy rating on the stock.

Olin (NYSE:OLN) had its target price lowered by UBS Group AG from $23.00 to $21.00. They currently have a neutral rating on the stock.

ProPetro (NYSE:PUMP) had its target price trimmed by Citigroup Inc. from $20.00 to $16.00. The firm currently has a buy rating on the stock.

Receive News & Ratings for Amylyx Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amylyx Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.